Published in J Clin Oncol on May 01, 2007
The effect of erythropoietin on normal and neoplastic cells. Biologics (2012) 0.98
Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells. Br J Cancer (2008) 0.96
Epo receptors are not detectable in primary human tumor tissue samples. PLoS One (2013) 0.90
EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors. PLoS One (2010) 0.85
Autocrine/paracrine erythropoietin regulates migration and invasion potential and the stemness of human breast cancer cells. Cancer Biol Ther (2013) 0.80
Recombinant human epoetin beta in the treatment of chemotherapy-related anemia. Ther Clin Risk Manag (2009) 0.77
Do erythropoietin receptors on cancer cells explain unexpected clinical findings? J Clin Oncol (2006) 5.56
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood (2005) 6.07
Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families. Blood (2011) 2.29
Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nat Genet (2009) 2.12
T-lymphocyte populations and cytokines in childhood nephrotic syndrome. Am J Kidney Dis (2002) 1.88
Mutational spectrum in congenital dyserythropoietic anemia type II: identification of 19 novel variants in SEC23B gene. Am J Hematol (2010) 1.60
Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood (2003) 1.58
Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2. Am J Hum Genet (2011) 1.37
p27Kip1 metabolism: a fascinating labyrinth. Cell Cycle (2007) 1.34
Von Hippel-Lindau-dependent polycythemia is endemic on the island of Ischia: identification of a novel cluster. Blood (2005) 1.26
Resveratrol: from basic science to the clinic. Cell Cycle (2007) 1.23
Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. Blood (2011) 1.23
Molecular analysis of 42 patients with congenital dyserythropoietic anemia type II: new mutations in the SEC23B gene and a search for a genotype-phenotype relationship. Haematologica (2009) 1.20
Red blood cell membrane defects. Rev Clin Exp Hematol (2003) 1.19
p21Cip1 gene expression is modulated by Egr1: a novel regulatory mechanism involved in the resveratrol antiproliferative effect. J Biol Chem (2003) 1.19
Genetic basis of congenital erythrocytosis: mutation update and online databases. Hum Mutat (2013) 1.18
p57(Kip2) and cancer: time for a critical appraisal. Mol Cancer Res (2011) 1.13
Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation. J Clin Invest (2014) 1.13
Targeting p27Kip1 protein: its relevance in the therapy of human cancer. Expert Opin Ther Targets (2011) 1.07
Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: a Webthal study. Circulation (2013) 1.06
The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: implications for band 3 function. Blood (2005) 1.02
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbα (Bolzano mutation). Haematologica (2011) 1.02
The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy. Bone (2011) 1.01
Association of breast cancer and polymorphisms of interleukin-10 and tumor necrosis factor-alpha genes. Clin Chem (2003) 1.00
Retinoic acid induces p27Kip1 nuclear accumulation by modulating its phosphorylation. Cancer Res (2006) 0.99
ROBO2 gene variants are associated with familial vesicoureteral reflux. J Am Soc Nephrol (2008) 0.98
PTPepsilon has a critical role in signaling transduction pathways and phosphoprotein network topology in red cells. Proteomics (2008) 0.96
Resveratrol: from basic studies to bedside. Cancer Treat Res (2014) 0.94
Frequency of congenital dyserythropoietic anemias in Europe. Eur J Haematol (2010) 0.94
Membrane association of peroxiredoxin-2 in red cells is mediated by the N-terminal cytoplasmic domain of band 3. Free Radic Biol Med (2012) 0.90
Reliability of EMA binding test in the diagnosis of hereditary spherocytosis in Italian patients. Acta Haematol (2010) 0.90
A genome search for primary vesicoureteral reflux shows further evidence for genetic heterogeneity. Pediatr Nephrol (2008) 0.90
Biological response of human bone marrow mesenchymal stem cells to fluoride-modified titanium surfaces. Clin Oral Implants Res (2010) 0.89
Caspase 3 and 8 deficiency in human neuroblastoma. Cancer Genet Cytogenet (2003) 0.89
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura. Haematologica (2011) 0.89
Congenital dyserythropoietic anemia type II: exclusion of seven candidate genes. Blood Cells Mol Dis (2003) 0.88
In vivo effect of the natural antioxidant hydroxytyrosol on cyclosporine nephrotoxicity in rats. Nephrol Dial Transplant (2007) 0.88
P27Kip1 serine 10 phosphorylation determines its metabolism and interaction with cyclin-dependent kinases. Cell Cycle (2014) 0.88
Spectrum of FANCA mutations in Italian Fanconi anemia patients: identification of six novel alleles and phenotypic characterization of the S858R variant. Hum Mutat (2003) 0.88
Retinoic acid inhibits the growth of bone marrow mesenchymal stem cells and induces p27Kip1 and p16INK4A up-regulation. Mol Cell Biochem (2003) 0.88
Renal hypoplasia without optic coloboma associated with PAX2 gene deletion. Nephrol Dial Transplant (2007) 0.88
The tyrosine kinase inhibitor dasatinib induces a marked adipogenic differentiation of human multipotent mesenchymal stromal cells. PLoS One (2011) 0.87
The effects of titanium nitride-coating on the topographic and biological features of TPS implant surfaces. J Dent (2011) 0.86
Congenital dyserythropoietic anemia type II: molecular analysis and expression of the SEC23B gene. Orphanet J Rare Dis (2011) 0.86
EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors. PLoS One (2010) 0.85
Splenectomy prolongs in vivo survival of erythrocytes differently in spectrin/ankyrin- and band 3-deficient hereditary spherocytosis. Blood (2002) 0.85
Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. Am J Hematol (2014) 0.85
Bone marrow mesenchymal stem cell response to nano-structured oxidized and turned titanium surfaces. Clin Oral Implants Res (2011) 0.84
Diverse effects of natural antioxidants on cyclosporin cytotoxicity in rat renal tubular cells. Nephrol Dial Transplant (2005) 0.84
p57Kip2 is a downstream effector of BCR-ABL kinase inhibitors in chronic myelogenous leukemia cells. Carcinogenesis (2010) 0.84
Proliferate and survive: cell division cycle and apoptosis in human neuroblastoma. Haematologica (2002) 0.84
Beta-spectrinBari: a truncated beta-chain responsible for dominant hereditary spherocytosis. Haematologica (2009) 0.83
Abnormalities of erythrocyte glycoconjugates are identical in two families with congenital dyserythropoietic anemia type II with different chromosomal localizations of the disease gene. Haematologica (2007) 0.83
The HIF2A gene in familial erythrocytosis. N Engl J Med (2008) 0.82
Splenectomy for hereditary spherocytosis: complete, partial or not at all? Expert Rev Hematol (2011) 0.82
Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor. Carcinogenesis (2008) 0.82
Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine-based reduced-intensity conditioning regimen. Br J Haematol (2002) 0.82
Development of hybrid materials based on hydroxyethylmethacrylate as supports for improving cell adhesion and proliferation. Biomaterials (2004) 0.82
Antioxidants induce different phenotypes by a distinct modulation of signal transduction. FEBS Lett (2002) 0.81
In vitro biologic response of human bone marrow stromal cells to enamel matrix derivative. J Periodontol (2007) 0.81
Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation. Hum Mutat (2005) 0.81
Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range. Haematologica (2013) 0.81
Inappropriate leptin secretion in thalassemia: a potential cofactor of pubertal timing derangement. J Pediatr Endocrinol Metab (2003) 0.81
Erythropoietin treatment can prevent blood transfusion in infantile pyknocytosis. Br J Haematol (2008) 0.80
Human gingival fibroblast functions are stimulated by oxidized nano-structured titanium surfaces. J Dent (2013) 0.79